TRAVERE THERAPEUTICS INC's ticker is TVTX and the CUSIP is 89422G107. A total of 174 filers reported holding TRAVERE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.74 and the average weighting 0.1%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Finepoint Capital LP | 895,821 | $8,008,640 | 3.99% |
| Deep Track Capital, LP | 7,370,000 | $65,887,800 | 2.54% |
| VR Adviser, LLC | 2,623,677 | $23,455,672 | 2.47% |
| Sio Capital Management, LLC | 884,770 | $7,909,844 | 2.45% |
| Kynam Capital Management, LP | 957,502 | $8,560,068 | 1.40% |
| MPM BioImpact LLC | 552,846 | $4,942,443 | 1.32% |
| ARMISTICE CAPITAL, LLC | 7,500,000 | $67,050,000 | 1.03% |
| Parkman Healthcare Partners LLC | 577,494 | $5,162,796 | 0.95% |
| Tri Locum Partners LP | 251,702 | $2,250,216 | 0.72% |
| Cheyne Capital Management (UK) LLP | 26,200 | $234,228 | 0.68% |
| MANGROVE PARTNERS IM, LLC | 945,417 | $8,452,028 | 0.64% |
| Birchview Capital, LP | 82,000 | $733,080 | 0.62% |
| HighVista Strategies LLC | 122,400 | $1,094,256 | 0.51% |
| Avidity Partners Management LP | 1,323,000 | $11,827,620 | 0.48% |
| EMERALD ADVISERS, LLC | 1,060,302 | $9,479,097 | 0.46% |
| Ghost Tree Capital, LLC | 150,000 | $1,341,000 | 0.44% |
| Rock Springs Capital Management LP | 1,807,742 | $16,161,213 | 0.43% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 764,603 | $6,835,551 | 0.41% |
| Octagon Capital Advisors LP | 300,000 | $2,682,000 | 0.41% |
| Knott David M Jr | 100,317 | $897 | 0.34% |
External links
This page lists TRAVERE THERAPEUTICS INC's shareholders in Q3 2023. To view TRAVERE THERAPEUTICS INC's shareholder history, click here.